๐ฐ Exscientia News
Page 2 - Exscientia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exscientia. Real-time updates on events, politics, business and more.
December 22, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report) shares dropped 5.2% on Wednesday . The company traded as low as $6.31 and last traded at $6.40. Approximately 133,619 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 442,768 shares. The stock had previously closed at $6.75. Wall Street Analyst […]
December 21, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report) shares traded up 6.8% during trading on Monday . The stock traded as high as $6.29 and last traded at $6.27. 748,304 shares changed hands during trading, an increase of 69% from the average session volume of 442,287 shares. The stock had previously closed at $5.87. Wall Street […]
December 21, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $6.14, but opened at $6.36. Exscientia shares last traded at $6.55, with a volume of 61,672 shares. Analysts Set New Price Targets Several equities research analysts have issued reports on the […]
December 19, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 3,060,000 shares, a drop of 11.0% from the November 15th total of 3,440,000 shares. Based on an average daily volume of 679,000 shares, the […]
December 19, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 3,060,000 shares, a drop of 11.0% from the November 15th total of 3,440,000 shares. Currently, 2.6% of the shares of the company are sold […]
December 19, 2023
Despite artificial intelligenceโs growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say itโs too early to focus on winning a race that has many twists and turns yet to come.
December 10, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report) fell 3.3% during mid-day trading on Friday . The stock traded as low as $5.47 and last traded at $5.63. 106,208 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 431,977 shares. The stock had previously closed at $5.82. Analyst Upgrades […]
November 29, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report)’s share price traded down 4.2% during mid-day trading on Monday . The company traded as low as $5.93 and last traded at $5.94. 55,902 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 433,195 shares. The stock had previously closed at […]
November 13, 2023
Exscientia plc (NASDAQ:EXAI – Get Free Report)’s stock price traded down 4.4% during trading on Monday . The stock traded as low as $5.00 and last traded at $5.03. 52,105 shares were traded during trading, a decline of 88% from the average session volume of 430,774 shares. The stock had previously closed at $5.26. Wall […]
October 20, 2023
Prof Andrew Hopkins' company uses AI for the discovery and creation of medicine.